UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.740

Sortiert nach

Synthesis and Antimycobacterial Activity of Pyrazine and Quinoxaline Derivatives

Journal of medicinal chemistry, 2002-12, Vol.45 (25), p.5604-5606

2002

Volltextzugriff (PDF)

Screening and Development of New Inhibitors of FtsZ from M. Tuberculosis

PloS one, 2016-10, Vol.11 (10), p.e0164100

2016

Volltextzugriff (PDF)

Enhancing hit identification in Mycobacterium tuberculosis drug discovery using validated dual-event Bayesian models

PloS one, 2013-05, Vol.8 (5), p.e63240

2013

Volltextzugriff (PDF)

High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv

Tuberculosis (Edinburgh, Scotland), 2009-09, Vol.89 (5), p.334-353

2009

Volltextzugriff (PDF)

Preclinical Testing of the Nitroimidazopyran PA-824 for Activity against Mycobacterium tuberculosis in a Series of In Vitro and In Vivo Models

Antimicrobial Agents and Chemotherapy, 2005-06, Vol.49 (6), p.2294-2301

2005

Volltextzugriff (PDF)

Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G

Molecular cancer therapeutics, 2009-12, Vol.8 (12), p.3331-3340

2009

Volltextzugriff (PDF)

Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria

PloS one, 2007-12, Vol.2 (12), p.e1343-e1343

2007

Volltextzugriff (PDF)

EthA, a Common Activator of Thiocarbamide-Containing Drugs Acting on Different Mycobacterial Targets

Antimicrobial Agents and Chemotherapy, 2007-03, Vol.51 (3), p.1055-1063

2007

Volltextzugriff (PDF)

Antituberculosis activity of the molecular libraries screening center network library

Tuberculosis (Edinburgh, Scotland), 2009-09, Vol.89 (5), p.354-363

2009

Volltextzugriff (PDF)

Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target

PloS one, 2014-11, Vol.9 (11), p.e113568-e113568

2014

Volltextzugriff (PDF)

Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats

Cancers, 2023-01, Vol.15 (3), p.646

2023

Volltextzugriff (PDF)

High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv

Tuberculosis (Edinburgh, Scotland), 2012-01, Vol.92 (1), p.72-83

2012

Volltextzugriff (PDF)

Identification of novel Mt-Guab2 inhibitor series active against M. tuberculosis

PloS one, 2012-03, Vol.7 (3), p.e33886-e33886

2012

Volltextzugriff (PDF)

Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis

Journal of medicinal chemistry, 2020-09, Vol.63 (17), p.8917-8955

2020

Volltextzugriff (PDF)

Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells

Cellular signalling, 2012-12, Vol.24 (12), p.2291-2296

2012

Volltextzugriff (PDF)

Structure of Mycobacterium tuberculosis FtsZ Reveals Unexpected, G Protein-like Conformational Switches

Journal of molecular biology, 2004-09, Vol.342 (3), p.953-970

2004

Volltextzugriff (PDF)

Novel Boron-Containing, Nonclassical Antifolates: Synthesis and Preliminary Biological and Structural Evaluation

Journal of medicinal chemistry, 2007-07, Vol.50 (14), p.3283-3289

2007

Volltextzugriff (PDF)

Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug Discovery

Molecular pharmaceutics, 2018-10, Vol.15 (10), p.4346-4360

2018

Volltextzugriff (PDF)

Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets

Journal of chemical information and modeling, 2015-06, Vol.55 (6), p.1231-1245

2015

Volltextzugriff (PDF)

Targeted degrader technologies as prospective SARS-CoV-2 therapies

Drug discovery today, 2024-01, Vol.29 (1), p.103847-103847, Article 103847

2024

Volltextzugriff (PDF)

Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis

Molecular microbiology, 2009-03, Vol.71 (5), p.1263-1277

2009

Volltextzugriff (PDF)

Are Bigger Data Sets Better for Machine Learning? Fusing Single-Point and Dual-Event Dose Response Data for Mycobacterium tuberculosis

Journal of chemical information and modeling, 2014-07, Vol.54 (7), p.2157-2165

2014

Volltextzugriff (PDF)

A novel quinoline derivative that inhibits mycobacterial FtsZ

Tuberculosis (Edinburgh, Scotland), 2013-07, Vol.93 (4), p.398-400

2013

Volltextzugriff (PDF)

Fusing Dual-Event Data Sets for Mycobacterium tuberculosis Machine Learning Models and Their Evaluation

Journal of chemical information and modeling, 2013-11, Vol.53 (11), p.3054-3063

2013

Volltextzugriff (PDF)

Synthesis of Aza-acyclic Nucleoside Libraries of Purine, Pyrimidine, and 1,2,4-Triazole

ACS combinatorial science, 2019-03, Vol.21 (3), p.183-191

2019

Volltextzugriff (PDF)

1 – 25 von 1.740

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.491)
Mit Volltextzugriff
(1.512)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Synthesis and Antimycobacterial Activity of Pyrazine and Quinoxaline Derivatives

Screening and Development of New Inhibitors of FtsZ from M. Tuberculosis

Enhancing hit identification in Mycobacterium tuberculosis drug discovery using validated dual-event Bayesian models

High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv

Preclinical Testing of the Nitroimidazopyran PA-824 for Activity against Mycobacterium tuberculosis in a Series of In Vitro and In Vivo Models

Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G

Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria

EthA, a Common Activator of Thiocarbamide-Containing Drugs Acting on Different Mycobacterial Targets

Antituberculosis activity of the molecular libraries screening center network library

Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target

Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats

High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv

Identification of novel Mt-Guab2 inhibitor series active against M. tuberculosis

Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis

Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells

Structure of Mycobacterium tuberculosis FtsZ Reveals Unexpected, G Protein-like Conformational Switches

Novel Boron-Containing, Nonclassical Antifolates: Synthesis and Preliminary Biological and Structural Evaluation

Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug Discovery

Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets

Targeted degrader technologies as prospective SARS-CoV-2 therapies

Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis

Are Bigger Data Sets Better for Machine Learning? Fusing Single-Point and Dual-Event Dose Response Data for Mycobacterium tuberculosis

A novel quinoline derivative that inhibits mycobacterial FtsZ

Fusing Dual-Event Data Sets for Mycobacterium tuberculosis Machine Learning Models and Their Evaluation

Synthesis of Aza-acyclic Nucleoside Libraries of Purine, Pyrimidine, and 1,2,4-Triazole

Suchergebnisse filtern